Nation-Wide Infusion Pump Product Recalls Intensifies Market Competition
VANCOUVER, May 17 /PRNewswire/- According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device market research, the U.S. infusion therapy device market will exceed $5 billion in 2010, which include
"Medicare and major insurance companies are no longer reimbursing for vascular access associated infections," says Dr. Kamran Zamanian, CEO of iData. "Facilities must absorb the costs of treating such patients and as a result, hospitals are purchasing premium-priced antimicrobial needleless connectors making this segment the fastest-growing in the market with almost 70% growth in 2010. This market is dominated by Baxter's first-to-market V-LinkŪ Luer Activated Device, however ICU Medical and B. Braun are expected to gain market share over the forecast period."
In addition, the report states that due to budgetary constraints, hospitals and private clinics are purchasing less-expensive disposable infusion pumps, boosting sales in the single-use ambulatory infusion pump market. Ambulatory and syringe infusion pumps is also growing at strong rates due to increasing use in the home-care and alternate clinical settings. However, nation-wide product recalls have limited market potential and intensified competition among top manufacturers such as CareFusion, Baxter, Hospira, I-Flow, Moog and Smiths Medical. It has also opened up opportunities for new companies to enter and new technologies to be introduced and gain dominance.
iData's report on "The U.S. Market for Infusion Therapy Devices 2011" includes the latest data, market-analyses and competitor profiles for over 17 segments.
For more information, register free on iData's website at: http://www.idataresearch.net/idata/registration.php
About iData Research
iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: vascular access, interventional cardiology, peripheral vascular, cardiac surgery and more.
SOURCE iData Research Inc.
Subscribe to our Free Newsletters!
Abortion pills are used in the first trimester to terminate pregnancy. Women should be aware of ...
Tea tree oil is an essential oil derived from the leaves of the Melaleuca alternifolia plant and ...
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...View All